Division of Critical Care Medicine, Department of Hospital Medicine, Inha University College of Medicine, Incheon, Republic of Korea.
Division of Critical Care Medicine, Department of Hospital Medicine, Inha University College of Medicine, Incheon, Republic of Korea; Division of Cardiology, Department of Internal Medicine, Inha University College of Medicine, Incheon, Republic of Korea.
Ann Palliat Med. 2022 Oct;11(10):3341-3345. doi: 10.21037/apm-22-178. Epub 2022 May 12.
Effective pharmacological options for acute hypoxemic or hypercapnic respiratory failure, associated with obesity hypoventilation syndrome (OHS), have not been fully elucidated. Although weight reduction, non-invasive ventilation (NIV), and continuous positive airway pressure (CPAP) lead to improvements in long-term clinical outcomes and cardiac function, there is no rapid reversal method in serious situations requiring mechanical ventilation. Veno-venous extracorporeal life support by extracorporeal membrane oxygenation is a widely used modality that can support patients with refractory hypoxemia or hypercapnia as a bridging therapy for recovery.
We present the case of a morbidly obese [body mass index (BMI) of 42 kg/m2] 58-year-old man with refractory hypoxemic respiratory failure, resulting from severe right ventricular failure and pulmonary hypertension (PH), who underwent emergency support with extracorporeal membrane oxygenation. During extracorporeal life support and mechanical ventilation, careful diuresis and nutritional control were provided for body weight loss, and body weight was significantly reduced by approximately 30 kg. Nocturnal NIV was initiated immediately after cessation of positive pressure ventilation and endotracheal intubation. After 5 weeks of hospitalization, transthoracic echocardiography (TTE) showed robust improvements in right ventricular cardiac function and PH.
Here, we describe that veno-venous extracorporeal life support may sufficiently support patients with obesity and sleep hypoventilation who have suffered a pulmonary hypertensive crisis.
肥胖低通气综合征(OHS)相关的急性低氧或高碳酸血症呼吸衰竭的有效药物治疗选择尚未完全阐明。虽然减重、无创通气(NIV)和持续气道正压通气(CPAP)可改善长期临床结局和心功能,但在需要机械通气的严重情况下,没有快速逆转的方法。体外膜氧合的静脉-静脉体外生命支持是一种广泛应用的方法,可以支持难治性低氧血症或高碳酸血症患者,作为恢复的桥接治疗。
我们报告了一例患有严重右心衰竭和肺动脉高压(PH)的病态肥胖[体重指数(BMI)为 42 kg/m2]58 岁男性患者,因严重低氧性呼吸衰竭而接受体外膜氧合紧急支持。在体外生命支持和机械通气期间,通过精心的利尿和营养控制来减轻体重,体重显著减轻了约 30 公斤。在停止正压通气和气管插管后,立即开始夜间 NIV。住院 5 周后,经胸超声心动图(TTE)显示右心室心功能和 PH 明显改善。
在这里,我们描述了静脉-静脉体外生命支持可能足以支持患有肥胖和睡眠性通气不足并发生肺动脉高压危象的患者。